• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Diabetes . Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Infections among Diabetics: a Retrospective and Multicenter Study in

tetano

Editor, Senior Moderator
J Diabetes


. 2020 Jul 29.
doi: 10.1111/1753-0407.13098. Online ahead of print.
Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Infections among Diabetics: a Retrospective and Multicenter Study in China


Huahua Yi[SUP] 1 2 [/SUP], Fangying Lu[SUP] 1 2 [/SUP], Xiaoyan Jin[SUP] 3 [/SUP], Rong Chen[SUP] 1 2 [/SUP], Bing Liu[SUP] 1 2 [/SUP], Xuan Dong[SUP] 4 [/SUP], Weining Xiong[SUP] 5 [/SUP], Dexiang Yang[SUP] 6 [/SUP], Yi Guo[SUP] 1 2 [/SUP], Min Zhou[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) emerged in Dec 2019 and has spread globally. Diabetics are at increased risk of infections caused by a variety of pathogens including virus. The present research was aimed to describe clinical characteristics and outcomes of COVID-19 patients with diabetes.
Methods: A retrospective multicenter study of COVID-19 patients with diabetes was conducted in four hospitals in Wuhan, Shanghai and Anhui Province. RT-PCR or next generation sequencing was executed to confirm the existence of SARS-CoV-2 from respiratory specimens.
Results: 54 diabetics (10.36%) were recruited from 521 COVID-19 patients, with a median age of 63 (IQR, 52-70) years. Among them, 51 were previously diagnosed with diabetes and 3 were newly diagnosed based on HbA[SUB]1c[/SUB] over 6.5%. For COVID-19, 47 of the 54 patients had an exposure history. Fever (47/54, 87.04%), dry cough (36/54, 66.67%) and expectoration (21/53, 39.62%) were among the top three symptoms. Lung infiltration was bilateral (46/52, 88.46%) and multilobe (47/52, 90.38%), and ground-glass opacity (36/37, 97.30%) was the most common pattern in radiological images. Besides, COVID-19 patients with diabetes were prone to be classified as severe or critical type (46.30%, 25/54) and complicated with acute lung injury, acute respiratory distress syndrome and acute kidney injury. The proportion of ICU admission and death among the COVID-19 diabetics were 14.81% (8/54) and 12.96% (7/54), respectively.
Conclusions: With older age, diabetics diagnosed as COVID-19 were prone to developing into severe type, and exhibited a high rate of ICU admission and mortality. This article is protected by copyright. All rights reserved.

Keywords: clinical feature; coronavirus disease 2019; diabetes; outcome.
 
Back
Top Bottom